TY - CHAP
T1 - Management of Gastrointestinal Disorders and the Pharmacist's Role: Gastroesophageal Reflux Disease
T2 - GERD
AU - Nirwan, Jorabar
AU - Yousaf, Maria
AU - Conway, Barbara
AU - Ghori, Muhammad Usman
PY - 2019/6/20
Y1 - 2019/6/20
N2 - Gastroesophageal reflux disease (GERD) is a chronic disorder caused by abnormal reflux of stomach contents into the esophagus. This event occurs primarily because of relaxation of the transient lower esophageal sphincter. Non-pharmacological intervention includes behavioral changes and lifestyle modifications Pharmacological interventions, many of which are available without prescription include administration of antacids, H2-receptor antagonists, proton pump inhibitors and alginate-based raft formulations. If these treatment strategies fail, the patient may undergo surgery (fundoplication). Pharmacists can manage mild and, to some extent, moderate symptoms of GERD either by recommending lifestyle changes to the patient or by recommending certain medications depending upon the signs and symptoms of the patients. They can also verify diagnosis, refer on any alarming symptoms, manage appropriate medication plans and address any adverse reactions or interactions.
AB - Gastroesophageal reflux disease (GERD) is a chronic disorder caused by abnormal reflux of stomach contents into the esophagus. This event occurs primarily because of relaxation of the transient lower esophageal sphincter. Non-pharmacological intervention includes behavioral changes and lifestyle modifications Pharmacological interventions, many of which are available without prescription include administration of antacids, H2-receptor antagonists, proton pump inhibitors and alginate-based raft formulations. If these treatment strategies fail, the patient may undergo surgery (fundoplication). Pharmacists can manage mild and, to some extent, moderate symptoms of GERD either by recommending lifestyle changes to the patient or by recommending certain medications depending upon the signs and symptoms of the patients. They can also verify diagnosis, refer on any alarming symptoms, manage appropriate medication plans and address any adverse reactions or interactions.
KW - Alginate-based raft formulations
KW - Diagnosis
KW - Gastroesophageal reflux disease
KW - GERD
KW - Management strategies
KW - Nonraft-based formulations
KW - Pathophysiology
KW - Risk factors
KW - Role of pharmacist
KW - Signs and symptoms
UR - https://www.elsevier.com/books/encyclopedia-of-pharmacy-practice-and-clinical-pharmacy/babar/978-0-12-812735-3
UR - http://www.scopus.com/inward/record.url?scp=85174760388&partnerID=8YFLogxK
M3 - Entry for encyclopedia/dictionary
SN - 9780128127353
BT - Encyclopedia of Pharmacy Practice and Clinical Pharmacy
A2 - Babar, Zaheer-Ud-Din
PB - Elsevier Ltd
ER -